MACOM Technology vs Relay Therapeutics Inc. Common Stock — how do they compare? MACOM Technology trades at $331 (market cap $24.61B), while Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B). The key difference: MACOM Technology is far larger — about 6.4× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is more actively traded (4,332,079 versus 1,594,575). Which is the better fit depends on your goals — on Pluang, investors hold MACOM Technology for 6 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| MTSI | RLAY | |
|---|---|---|
Market Cap | $24.61B | $3.82B |
Volume | 1,594,575 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $409.68 | $20.75 |
52-Week Low | $122.18 | $6.03 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $24.32B | $2.93B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →